Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization, a Non-randomized, Prospective, Open-label Registry in Real-world Practice
Seung-Jung Park
200 participants
Apr 5, 2019
OBSERVATIONAL
Conditions
Summary
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Eligibility
Inclusion Criteria3
- Age 20 and more
- Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
- Written consent
Exclusion Criteria2
- Previous CABG(coronary artery bypass graft)
- Life expectancy ≤1 year
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03788369